Фармацевтична адаптація до нових викликів у сфері охорони здоров'я, спричинених Сovid 19 в Алжирі: тенденція розвитку фармацевтичного менеджменту
DOI:
https://doi.org/10.26661/2522-1566/2024-2/28-04Ключові слова:
Covid-19; фармацевтичний менеджмент; розвиток; фармацевтична адаптація; фармацевти; викликиАнотація
Мета статті - визначити, якою мірою фармацевти адаптуються до зростаючих потреб клієнтів в епоху covid-19. І фармацевти, і їхні клієнти стикаються з п'ятьма викликами: поширенням інфекцій, доступом до ліків, самолікуванням, управлінням роботою та навчанням персоналу. Для цього у вересні-листопаді 2023 року в регіоні, розташованому на крайньому заході Алжиру, було проведено тематичне онлайн дослідження з використанням напівструктурованого інтерв'ю щодо основних викликів, з якими зіткнулися 50 аптек у період covid-19, щоб описати роль аптек та обговорити їхні майбутні функції. Потім, щоб виміряти ступінь нагальності та важливості викликів, з якими ми зіткнулися, ми застосували матрицю Ейзенхауера, використовуючи шкалу Лайкерта (з 05 варіантів відповідей) за допомогою програмного забезпечення Sphinx plus. Потім ми застосували той самий інструмент аналізу до вибірки з 138 клієнтів, щоб виявити ступінь їхньої фармацевтичної адаптації. Це дослідження виявило високий ступінь адаптації (важливості/нагальності) аптек по відношенню до своїх клієнтів для п'яти згаданих вище викликів: (4,94-4,98) / (5/5) для поширення інфекцій; (4,56-4,94) / (3,97-4,57) для доступу до лікарських засобів; (3,98/1,66) проти (3,88-1,54) для самолікування. (1,60-3,38) проти (1,57-3,39) для управління роботою та (3,40-1,66) проти (3,46-1,37) для навчання. Ці результати збігаються з концепцією фармацевтичної адаптації, яка є тенденцією розвитку інновацій у фармацевтичному менеджменті.
JEL Classification: H12, M12
Посилання
Akande-Sholabi W, Adebisi YA. (2020).The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan Afr Med J. 35 (2): 73. https://doi.org/10.11604/pamj.supp.2020.35.2.23671
Al-Haqan A, Alenezi F, Al-Mutairi S et al. (2022). Are pharmacists well equipped to deal with global health emergencies? Burnout during COVID-19. J Pharm Health Serv Res 2022; 13 (1): 9-16. https://doi.org/10.1093/jphsr/rmab067
Anderson N, Potočnik K, Zhou J. (2014). Innovation and Creativity in Organizations: A State-of-the-Science Review, Prospective Commentary, and Guiding Framework. J Manage. 40 (5): 1297-333. https://doi.org/10.1177/0149206314527128
Annosi MC, Magnusson M, Martini A, et al. (2016). Social Conduct, Learning and Innovation: An Abductive Study of the Dark Side of Agile Software Development. Creativity Innov Manag. 25 (4): 515-535. https://doi.org/10.1111/caim.12172
Baratta F, Visentin G, Enri LR et al (2021). Community Pharmacy Practice in Italyduring the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence. Int J Environ Res Public Health. 18 (5): 1-13. https://doi.org/10.3390/ijerph18052302
Bragazzi NL, Mansour M, Bonsignore A et al. (2020). The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharm. 8 (3):1-15. https://doi.org/10.3390/pharmacy8030140
Bratterud, H., Burgess, M., Fasy, B.T., Millman, D.L., Oster, T., Sung, E.. (2020). The Sung Diagram: Revitalizing the Eisenhower Matrix. In: Pietarinen, AV., Chapman, P., Bosveld-de Smet, L., Giardino, V., Corter, J., Linker, S. (eds) Diagrammatic Representation and Inference. Diagrams 2020. Lecture Notes in Computer Science, vol 12169. Springer, Cham. https://doi.org/10.1007/978-3-030-54249-8_43
Cadogan C A, Hughes CM. (2021). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm. 17(1): 2032-35. https://doi.org/10.1016/j.sapharm.2020.03.015
Chi Z M, Renukha S, Jason S E L. (2021). The prevalence and perception of self-medication among adults in the Klang Valley, Malaysia. Int J Pharm Pract. 29 (1): 29–36. https://doi.org/10.1111/ijpp.12660
Datoussaid A, Hamadi A, Ezzine A. (2021). Indigenous tacit knowledge of traditional medicine against COVID-19 in Algeria, J Manag Spiritual Relig.18 (5): 444-461. https://doi.org/10.51327/WDBD2443
Djeflat A. (2021). Le Coronavirus et l'économie de la connaissance : les effets différenciés dans le Nord et dans le Sud. Revue Marocaine d’Audit et de Développement. 51: 43-60
Djeflat A. (2022) Le coronavirus et l’importance de l’insertion dans l’Économie de la connaissance : une lecture évolutionniste. Marché et Organisations. 1 (43): 65-84. https://doi.org/10.3917/maorg.043.0065
Djellal F, Gallouj F. (2006). Innovation in care services for the elderly. Serv Ind J 2006; 26 (3): 303-27. https://doi.org/ 10.1080/02642060600570943
Hamadi A, Datoussaid A. (2019). Endogenous institutional change in favor of access to medicines: the case of Algeria. El-Bahith Review. 19 (1): 541-549.
Hamadi A, Datoussaid A. Dif A. (2017) Politique publique industrielle en faveur des PMEs pharmaceutiques algériennes. Revue des sciences humaines. 17 (2): 12-31.
Hamadi A, Jou S, Datoussaid A. (2022). Access to COVID-19 vaccines: inequality between developed and developing countries. Les cahiers du Mecas. 17 (4): 1-8.
Hayden J, Parkin R. (2020).The challenges of COVID-19 for community pharmacists and opportunities for the future. Ir J Psychol Med. 37 : 198-203. https://doi.org/10.1017/ipm.2020.52
Jou S, Datoussaid A. (2023). Les pharmaciens d'officines et le service pharmaceutique en Algérie : leçons tirées de la crise sanitaire COVID-19. Les cahiers du Mecas. 19 (1) : 54-64
Kala’lembang, A. (2021), Digitalization in increasing SMEs productivity in the post COVID-19 pandemic period, Management and entrepreneurship: trends of development. 2(16). 101-110. https://doi.org/10.26661/2522-1566/2021-1/16-08
Marwitz KK, Haugtvedt C, Kostrzewa AB. (2021). Support Pharmacy Infrastructure to Strengthen US COVID-19 vaccination efforts and beyond. Am J Public Health. 111: 1204-06. https://doi.org/10.2105/AJPH.2021.306314
Matias T, Dominski DF. (2020). Human needs in COVID-19. isolation. J Health Psychol. 25 (7): 871-82. https://doi.org/10.1177/1359105320925149
Morawska L, Cao J. (2020). Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int. 139: 1-3. https://doi.org/10.1016/j.envint.2020.105730
Nadia AM, Rana MI, Al Meslamani AZ et al. (2021). The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. Int J Pharm Pract. 29 (2): 137–144. https://doi.org/10.1093/ijpp/riaa003
Nazanin F, Corey M, Centaine L S. (2021). The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis. Int J Pharm Pract 2021; 29 (2): 152–156. https://doi.org/10.1093/ijpp/riaa017
Savitri E, Emrinaldi NP, Syahza A. (2021). Can innovation mediate the effect of adaptability, entrepreneurial orientation on business performance? Manag Sci Lett. 11: 2301-12. https://doi.org/10.5267/j.msl.2021.3.014
Smith MB, Webster BD. (2018). Narcissus the innovator? The relationship between grandiose narcissism, innovation, and adaptability. Pers Individ Differ. 121 (15): 67-73. https://doi.org/10.1016/j.paid.2017.09.018
Tuominen M, Rajala A, Möller K. (2004). How does adaptability drive firm innovativeness? J Bus Res 2004; 57 (5): 495-506. https://doi.org/10.1016/S0148-2963(02)00316-8
WHO. (2021). Therapeutics and COVID-19: living guideline, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2021.1 (20 April 2021, date last accessed).
WHO. (2023). Guidelines for the regulatory assessment of medicinal products for use in self-medication, 2023. https://apps.who.int/iris/handle/10665/66154 (20 August 2023, date last accessed).
Widya Adhariyanty R ., Adriani K, (2023). Analysis of the role and motivation of human capital in the post-pandemic period of covid-19. Management and entrepreneurship: trends of development. 1(23). 29-36. https://doi.org/10.26661/2522-1566/2023-1/23-03
Zachary Z, Charmane JW. (2021). Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm; 17(1): 1845-52. https://doi.org/10.1016/j.sapharm.2020.06.014
Al-Haqan A, Alenezi F, Al-Mutairi S et al. (2022). Are pharmacists well equipped to deal with global health emergencies? Burnout during COVID-19. J Pharm Health Serv Res 2022; 13 (1): 9-16. https://doi.org/10.1093/jphsr/rmab067
Anderson N, Potočnik K, Zhou J. (2014). Innovation and Creativity in Organizations: A State-of-the-Science Review, Prospective Commentary, and Guiding Framework. J Manage. 40 (5): 1297-333. https://doi.org/10.1177/0149206314527128
Annosi MC, Magnusson M, Martini A, et al. (2016). Social Conduct, Learning and Innovation: An Abductive Study of the Dark Side of Agile Software Development. Creativity Innov Manag. 25 (4): 515-535. https://doi.org/10.1111/caim.12172
Baratta F, Visentin G, Enri LR et al (2021). Community Pharmacy Practice in Italyduring the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence. Int J Environ Res Public Health. 18 (5): 1-13. https://doi.org/10.3390/ijerph18052302
Bragazzi NL, Mansour M, Bonsignore A et al. (2020). The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharm. 8 (3):1-15. https://doi.org/10.3390/pharmacy8030140
Bratterud, H., Burgess, M., Fasy, B.T., Millman, D.L., Oster, T., Sung, E.. (2020). The Sung Diagram: Revitalizing the Eisenhower Matrix. In: Pietarinen, AV., Chapman, P., Bosveld-de Smet, L., Giardino, V., Corter, J., Linker, S. (eds) Diagrammatic Representation and Inference. Diagrams 2020. Lecture Notes in Computer Science, vol 12169. Springer, Cham. https://doi.org/10.1007/978-3-030-54249-8_43
Cadogan C A, Hughes CM. (2021). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm. 17(1): 2032-35. https://doi.org/10.1016/j.sapharm.2020.03.015
Chi Z M, Renukha S, Jason S E L. (2021). The prevalence and perception of self-medication among adults in the Klang Valley, Malaysia. Int J Pharm Pract. 29 (1): 29–36. https://doi.org/10.1111/ijpp.12660
Datoussaid A, Hamadi A, Ezzine A. (2021). Indigenous tacit knowledge of traditional medicine against COVID-19 in Algeria, J Manag Spiritual Relig.18 (5): 444-461. https://doi.org/10.51327/WDBD2443
Djeflat A. (2021). Le Coronavirus et l'économie de la connaissance : les effets différenciés dans le Nord et dans le Sud. Revue Marocaine d’Audit et de Développement. 51: 43-60
Djeflat A. (2022) Le coronavirus et l’importance de l’insertion dans l’Économie de la connaissance : une lecture évolutionniste. Marché et Organisations. 1 (43): 65-84. https://doi.org/10.3917/maorg.043.0065
Djellal F, Gallouj F. (2006). Innovation in care services for the elderly. Serv Ind J 2006; 26 (3): 303-27. https://doi.org/ 10.1080/02642060600570943
Hamadi A, Datoussaid A. (2019). Endogenous institutional change in favor of access to medicines: the case of Algeria. El-Bahith Review. 19 (1): 541-549.
Hamadi A, Datoussaid A. Dif A. (2017) Politique publique industrielle en faveur des PMEs pharmaceutiques algériennes. Revue des sciences humaines. 17 (2): 12-31.
Hamadi A, Jou S, Datoussaid A. (2022). Access to COVID-19 vaccines: inequality between developed and developing countries. Les cahiers du Mecas. 17 (4): 1-8.
Hayden J, Parkin R. (2020).The challenges of COVID-19 for community pharmacists and opportunities for the future. Ir J Psychol Med. 37 : 198-203. https://doi.org/10.1017/ipm.2020.52
Jou S, Datoussaid A. (2023). Les pharmaciens d'officines et le service pharmaceutique en Algérie : leçons tirées de la crise sanitaire COVID-19. Les cahiers du Mecas. 19 (1) : 54-64
Kala’lembang, A. (2021), Digitalization in increasing SMEs productivity in the post COVID-19 pandemic period, Management and entrepreneurship: trends of development. 2(16). 101-110. https://doi.org/10.26661/2522-1566/2021-1/16-08
Marwitz KK, Haugtvedt C, Kostrzewa AB. (2021). Support Pharmacy Infrastructure to Strengthen US COVID-19 vaccination efforts and beyond. Am J Public Health. 111: 1204-06. https://doi.org/10.2105/AJPH.2021.306314
Matias T, Dominski DF. (2020). Human needs in COVID-19. isolation. J Health Psychol. 25 (7): 871-82. https://doi.org/10.1177/1359105320925149
Morawska L, Cao J. (2020). Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int. 139: 1-3. https://doi.org/10.1016/j.envint.2020.105730
Nadia AM, Rana MI, Al Meslamani AZ et al. (2021). The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge. Int J Pharm Pract. 29 (2): 137–144. https://doi.org/10.1093/ijpp/riaa003
Nazanin F, Corey M, Centaine L S. (2021). The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis. Int J Pharm Pract 2021; 29 (2): 152–156. https://doi.org/10.1093/ijpp/riaa017
Savitri E, Emrinaldi NP, Syahza A. (2021). Can innovation mediate the effect of adaptability, entrepreneurial orientation on business performance? Manag Sci Lett. 11: 2301-12. https://doi.org/10.5267/j.msl.2021.3.014
Smith MB, Webster BD. (2018). Narcissus the innovator? The relationship between grandiose narcissism, innovation, and adaptability. Pers Individ Differ. 121 (15): 67-73. https://doi.org/10.1016/j.paid.2017.09.018
Tuominen M, Rajala A, Möller K. (2004). How does adaptability drive firm innovativeness? J Bus Res 2004; 57 (5): 495-506. https://doi.org/10.1016/S0148-2963(02)00316-8
WHO. (2021). Therapeutics and COVID-19: living guideline, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2021.1 (20 April 2021, date last accessed).
WHO. (2023). Guidelines for the regulatory assessment of medicinal products for use in self-medication, 2023. https://apps.who.int/iris/handle/10665/66154 (20 August 2023, date last accessed).
Widya Adhariyanty R ., Adriani K, (2023). Analysis of the role and motivation of human capital in the post-pandemic period of covid-19. Management and entrepreneurship: trends of development. 1(23). 29-36. https://doi.org/10.26661/2522-1566/2023-1/23-03
Zachary Z, Charmane JW. (2021). Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm; 17(1): 1845-52. https://doi.org/10.1016/j.sapharm.2020.06.014
Завантаження
Опубліковано
2024-06-20
Номер
Розділ
Менеджмент
Як цитувати
Jou, S. (2024) “Фармацевтична адаптація до нових викликів у сфері охорони здоров’я, спричинених Сovid 19 в Алжирі: тенденція розвитку фармацевтичного менеджменту”, Менеджмент та підприємництво: тренди розвитку, 2(28), pp. 52–60. doi:10.26661/2522-1566/2024-2/28-04.
